Does Delivery Location Really Impact Gastroschisis Outcomes?
Dalton et al. (Journal of Pediatric Surgery, 2017) examined whether patients had improved outcomes based on whether they were treated at the delivery hospital (inborn) or transferred elsewhere for definitive treatment (outborn)
Single Center Retrospective Chart Review
Pediatric tertiary care center from 2010 to 2015
Pooled data from all patients with uncomplicated gastroschisis
Patients were categorized as:
Patients delivered within center (inborn)
Patients delivered outside of center (outborn)
63 patients with uncomplicated gastroschisis were included for analysis
Inborn characteristics, compared to outborn:
Shorter length of stay (30 vs 40 days; P=0.03)
Fewer TPN days (23 vs 32 days; P=0.03)
Lower 90-day readmission % rate (11 vs 22%; P=0.02)
Fewer total hospital days (31 vs 43 days; P=0.01)
Time to definitive closure was similar between groups
Mortality was 0% for both inborn and outborn patients
The authors recommend that since most infants with gastroschisis are diagnosed prenatally, delivery should be arranged in a center that can provide complete care for the mother but also has definitive treatment capabilities for the newborn
This paper confirms other studies that delivery outside a perinatal center is a significant independent predictor of poorer outcomes in uncomplicated gastroschisis (Nasr et al., Journal of Pediatric Surgery, 2012)
Please sign up or log in to your ObGFirst to access this Premium Content
Media - Internet
Computer System Requirements
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan